InBody Co Ltd
KOSDAQ:041830
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
InBody Co Ltd
Total Liabilities & Equity
InBody Co Ltd
Total Liabilities & Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
I
|
InBody Co Ltd
KOSDAQ:041830
|
Total Liabilities & Equity
₩361.1B
|
CAGR 3-Years
14%
|
CAGR 5-Years
17%
|
CAGR 10-Years
16%
|
|
|
I
|
I Sens Inc
KOSDAQ:099190
|
Total Liabilities & Equity
₩577.7B
|
CAGR 3-Years
9%
|
CAGR 5-Years
13%
|
CAGR 10-Years
12%
|
|
|
C
|
Classys Inc
KOSDAQ:214150
|
Total Liabilities & Equity
₩704.6B
|
CAGR 3-Years
29%
|
CAGR 5-Years
39%
|
CAGR 10-Years
50%
|
|
|
W
|
Won Tech Co Ltd
KOSDAQ:336570
|
Total Liabilities & Equity
₩177.9B
|
CAGR 3-Years
150%
|
CAGR 5-Years
73%
|
CAGR 10-Years
N/A
|
|
|
V
|
Viol Co Ltd
KOSDAQ:335890
|
Total Liabilities & Equity
₩98.1B
|
CAGR 3-Years
49%
|
CAGR 5-Years
55%
|
CAGR 10-Years
N/A
|
|
|
S
|
Seers Technology Co Ltd
KOSDAQ:458870
|
Total Liabilities & Equity
₩28.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
InBody Co Ltd
Glance View
InBody Co., Ltd. engages in the manufacture and sale of medical equipment. The company is headquartered in Seoul, Seoul. The company went IPO on 2000-12-14. The firm mainly produces body composition analyzers under the brand names of InBody and Lookin’Body. The firm mainly produces body composition analyzers under the brand name InBody and Lookin’Body. Its InBody series products include InBody720, InBody520, InBody230, InBody R20, InBody S20, InBody S10 and InBody J10. Its Lookin' series products include Lookin’Body3.0 and Lookin’Body Basic, which are used for measuring proteins, minerals, fats, moistures and others. The company also provides body mass index (BMI) measuring devices under the brand name of BSM. The firm distributes its products within domestic market and to overseas markets.
See Also
What is InBody Co Ltd's Total Liabilities & Equity?
Total Liabilities & Equity
361.1B
KRW
Based on the financial report for Dec 31, 2025, InBody Co Ltd's Total Liabilities & Equity amounts to 361.1B KRW.
What is InBody Co Ltd's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
16%
Over the last year, the Total Liabilities & Equity growth was 18%. The average annual Total Liabilities & Equity growth rates for InBody Co Ltd have been 14% over the past three years , 17% over the past five years , and 16% over the past ten years .
